Abbreviations GLP-1RA: Glucagon-Like Peptide-1 Receptor Agonists SGLT2: Sodiumglucose cotransporter 2 DPP4: Dipeptidyl Peptidase-4 T2D: Type 2 diabetes AF/Aflutter: Atrial fibrillation or flutter TSH: Thyroid-stimulating hormone MPR: Medication possession ratio PS: Propensity score IPCW: Inverse probability censoring weight SMD: Standardized mean differences References McCoy RG, Herrin J, Swarna KS, Deng Y, Kent DM, Ross JS, et al
The Triple Therapy program is intended for patients who do not meet the BMI requirements to start a GLP-1 program but still seek help managing their weight
said during the briefing
To test the possible increase in potency of the two drugs when given simultaneously, we injected a total volume of 4 ml of combined doses of L838,417 and CLP257 in a fixed dose ratio of \([{\mathrm{L 838,417]/[{\mathrm{CLP 257]\) = 1:55, given the relative EC50s of the two drugs calculated from the respective dose response curves with a priori assumption on the collapse at high doses of L838,417 (Fig
Think of it as a biological messenger
